Test Bank Pharmacology: A Patient-Centered
bg bg bg bg
Nursing Process Approach 11th Edition ISBN:
bg bg bg bg bg bg
9780323793155 Jennifer Yeager, Kathleen
b g bg bg bg
DiMaggio, Linda McCuistion, Mary Winton
bg bg bg bg bg
, Test Bank Pharmacology: A Patient-Centered Nursing Process Approach 11th Edition ISBN:
bg bg bg bg bg bg bg bg bg bg
9780323793155 Jennifer Yeager, Kathleen DiMaggio, Linda McCuistion, Mary Winton
bg bg bg bg bg bg bg bg bg
Table of Content
bg bg
1. Clinical Judgment Management Model (CJMM) and the Nursing Process
bg bg bg bg bg bg bg bg bg
2. Drug Development and Ethical Considerations
bg bg bg bg bg
3. Pharmacokinetics and Pharmacodynamics
bg bg bg
4. Pharmacogenetics
bg
5. Complementary and Alternative Therapies
bg bg bg bg
6. Pediatric Considerations
bg bg
7. Drug Therapy in Older Adults
bg bg bg bg bg
8. Drugs in Substance Use Disorder
bg bg bg bg bg
9. Safety and Quality
bg bg bg
10. Drug Administration
bg bg
11. Drug Calculations
bg bg
12. Fluid Volume and Electrolytes
bg bg bg bg
13. Vitamin and Mineral Replacement
bg bg bg bg
14. Nutritional Support
bg bg
15. Adrenergic Agonists and Antagonists
bg bg bg bg
16. Cholinergic Agonists and Antagonists
bg bg bg bg
17. Stimulants
bg
18. Depressants
bg
19. Antiseizure Drugs
bg bg
20. Drugs for Parkinsonism and Alzheimer Disease
bg bg bg bg bg bg
21. Drugs for Neuromuscular Disorders and Muscle Spasms
bg bg bg bg bg bg bg
22. Antipsychotics and Anxiolytics
bg bg bg
23. Antidepressants and Mood Stabilizers
bg bg bg bg
24. Antiinflammatories
bg
25. Analgesics
bg
26. Penicillins, Other Beta-Lactams, and Cephalosporins
bg bg bg bg bg
27. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides
bg bg bg bg bg bg bg
28. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones
bg bg bg bg bg
29. Sulfonamides and Nitroimidazoles Antibiotics
bg bg bg bg
30. Antituberculars, Antifungals, and Antivirals
bg bg bg bg
31. Antimalarials, Anthelmintics, and Peptides
bg bg bg bg
32. HIV- and AIDS-Related Drugs
bg bg bg bg
33. Transplant Drugs
bg bg
34. Vaccines
bg
35. Anticancer Drugs
bg bg
36. Targeted Therapies to Treat Cancer
bg bg bg bg bg
37. Biologic Response Modifiers
bg bg bg
38. Upper Respiratory Disorders
bg bg bg
,39. Lower Respiratory Disorders
bg bg bg
40. Cardiac Glycosides, Antianginals, and Antidysrhythmics
bg bg bg bg bg
41. Diuretics
bg
42. Antihypertensives
bg
43. Anticoagulants, Antiplatelets, and Thrombolytics
bg bg bg bg
44. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow
bg bg bg bg bg bg bg bg
45. Gastrointestinal Tract Disorders
bg bg bg
46. Antiulcer Drugs
bg bg
47. Eye and Ear Disorders
bg bg bg bg
48. Dermatologic Disorders
bg bg
49. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders
bg bg bg bg bg bg
50. Antidiabetics
bg
51. Urinary Disorders
bg bg
52. Pregnancy and Preterm Labor
bg bg bg bg
53. Labor, Delivery, and Postpartum
bg bg bg bg
54. Neonatal and Newborn
bg bg bg
55. Women’s Reproductive Health
bg bg bg
56. Men’s Reproductive Health
bg bg bg
57. Sexually Transmitted Infections
bg bg bg
58. Adult and Pediatric Emergency Drugs
bg bg bg bg bg
, Chapter 01: The Nursing Process and Patient-Centered Care
bg bg bg bg bg bg bg
McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition
bg bg bg bg bg bg bg bg
MULTIPLE CHOICE bg
1. All of the following would be considered subjective data, EXCEPT:
bg bg bg bg bg bg bg bg bg
a. Patient-reported health history bg bg
b. Patient-reported signs and symptoms of their illness bg bg bg bg bg bg
c. Financial barriers reported by the patient‘s caregiver
bg bg bg bg bg bg
d. Vital signs obtained from the medical record
bg bg bg bg bg bg
ANS: D bg
Subjective data is based on what patients or family members communicate to the nurse.
bg bg bg bg bg bg bg bg bg bg bg bg bg
Patient- reported health history, signs and symptoms, and caregiver reported financial
bg bg bg bg bg bg bg bg bg bg bg
barriers would be considered subjective data. Vital signs obtained from the medical record
bg bg bg bg bg bg bg bg bg bg bg bg bg
would be considered objective data.
bg bg bg bg bg
DIF: Cognitive Level: Understanding (Comprehension) bg bg bg TOP: Nursing Process:
bg bg
Planning MSC: NCLEX: Management of Client Care
bg bg b g bg bg bg bg
2. The nurse is using data collected to define a set of interventions to achieve the most
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg
desirable outcomes. Which of the following steps is the nurse applying?
bg bg bg bg bg bg bg bg bg bg bg
a. Recognizing cues (assessment) bg bg
b. Analyze cues & prioritize hypothesis (analysis)
bg bg bg bg bg
c. Generate solutions (planning) bg bg
d. Take action (nursing interventions)
bg bg bg
ANS: C bg
When generating solutions (planning), the nurse identifies expected outcomes and uses the
bg bg bg bg bg bg bg bg bg bg bg
patient‘s problem(s) to define a set of interventions to achieve the most desirable
bg bg bg bg bg bg bg bg bg bg bg bg bg
outcomes. Recognizing cues (assessment) involves the gathering of cues (information)
bg bg bg bg bg bg bg bg bg bg
from the patient about their health and lifestyle practices, which are important facts that
bg bg bg bg bg bg bg bg bg bg bg bg bg bg
aid the nurse in making clinical care decisions. Prioritizing hypothesis is used to organize
bg bg bg bg bg bg bg bg bg bg bg bg bg bg
and rank the patient problem(s) identified. Finally, taking action involves implementation of
bg bg bg bg bg bg bg bg bg bg bg bg
nursing interventions to accomplish the expected outcomes.
bg bg bg bg bg bg bg
DIF: Cognitive Level: Understanding bg bg
(Comprehension) TOP: Nursing Process: Nursing
bg bg b g bg bg
Intervention
bg
MSC: NCLEX: Management of Client Care
b g bg bg bg bg
3. A 5-year-old child with type 1 diabetes mellitus has had repeated hospitalizations for
bg bg bg bg bg bg bg bg bg bg bg bg
episodes of hyperglycemia. The parents tell the nurse that they can‘t keep track of
bg bg bg bg bg bg bg bg bg bg bg bg bg bg
everything that has to be done to care for their child. The nurse reviews medications, diet,
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg
and symptom management with the parents and draws up a daily checklist for the family
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg
to use. These activities are completed in which step of the nursing process?
bg bg bg bg bg bg bg bg bg bg bg bg bg
a. Recognizing cues (assessment) bg bg
b. Analyze cues & prioritize hypothesis (analysis)
bg bg bg bg bg